12
Clinovo 1208 E. Arques Avenue, Suite 114 Sunnyvale, CA 94085 [email protected] +1 800 987 6007 www.clinovo.com CONDUCTING POST MARKET REGISTRIES RATIONALE AND EXECUTION PRESENTATION FOR THE ACRP 2015 GLOBAL CONFERENCE & EXHIBITION Written by Ale Gicqueau, President and Founder at Clinovo

Conducting Post Market Registries

  • Upload
    clinovo

  • View
    62

  • Download
    0

Embed Size (px)

Citation preview

Clinovo1208 E. Arques Avenue, Suite 114Sunnyvale, CA [email protected]+1 800 987 6007 www.clinovo.com

CONDUCTING POST MARKET REGISTRIES

RATIONALE AND EXECUTIONPRESENTATION FOR THE ACRP 2015 GLOBAL CONFERENCE & EXHIBITION

Written by Ale Gicqueau, President and Founder at Clinovo

2© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Post market registries can provide valuable real-life data for publication,

reimbursement and improve the medical device and indication expansion.

Creating these registries require careful planning and coordination.

Clinical data is essential in providing clinical evidence for medical

products, and to better understand the device safety and efficacy after

clearance or approval. Clinical trials are becoming cost prohibitive as trials

require to follow Good Clinical Practice, to be closely monitored to ensure

data quality and to adhere to inclusion and exclusion criteria.

Clinical registries provide a real-life exposure to the use of the device, and

can provide valuable clinical data, if designed appropriately at a fraction

of the price of industry-sponsored clinical trials.

Abstract

3© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Registry Studies

Observational · Look backwards without dictating a treatment planObserve what was done

Not viewed as second-rate clinical trials

Clinical Trials

Investigational · Look forward to what shall be done

Dictate and control a treatment plan

Shows investigators how to do it

Registry Studies vs Clinical Trials

4© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Define the hypotheses related to safety, efficacy, and cost

Define endpoints or outcomes that will support or refute the

hypotheses

Inclusion and exclusion criteria for who will be in the study

Design of Registries

5© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Data Collection

Patient Demographics

Medical History

Health Status

Patient’s Experience with Technology or Device

Primary and Secondary Endpoints

Adverse Events

Technology Deficiencies

6© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

IRB approval

HIPAA waiver to access patient’s medical records

Financial Agreement with institution regarding payments, and

data ownership

Assurances of patient privacy

Ethics, Data Ownership, and Privacy

7© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Sites

Pay fair-market value for their time

Endorsed by leading organizations, and respected

opinion-leader

Provide useful self-assessment data to physician

Patients

Recruitment by patient’s own physician

Provide written materials in language easily understood by

public

Keep survey forms short and simple

Provide incentives

Recruitment

8© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Case Report Forms

Forms where data is gathered, entered into coded database, and

stored in a clinical database

Data Dictionary

Detailed description of each variable used in

the registry

Data Collection and Quality Assurance

9© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Monitoring

Verify that the subject exists

Verify that the subject has disease or condition under study

Subject met inclusion and exclusion criteria

Signed and informed consent and HIPAA authorization

Received or declined treatment

10© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Analysis and Interpretation

Determine how closely the study population represents the

population

Statistical analysis plan for how the data are to be analyzed and

interpreted with regard to accepting or refuting the hypothesis

Plan for how to handle missing data

11© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Conclusion

Registry Studies are a great mean for large clinical data collection

They appear as a great tool for market expansion

Choosing the appropriate database that tailors your needs and

capabilities is key

Many solutions such as ClinCapture are available today and can

provide a scalable and cost effective solutions

12© 2015 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo

Contact

Please contact us for more information!

[email protected]

Visit our Blog for more interesting topics

www.clinovo.com/blog

Visit our website to learn about our EDC system ClinCapture

www.clinovo.com